Company profile

STRYKER CORP

NYSE:SYKMedical/Dental Instruments

Clinical trials (3)

NCT IDPhaseStatusStartCompletionSponsor nameTitle
NCT00456157phase1completed2007-03-01Stryker BiotechA Phase 1, Double-Blind, Randomized, Single Dose Escalation Safety Study of Intra-articular OP-1 in Subjects With Osteoarthritis of the Knee
NCT01111045phase2completed2010-04-012011-08-01Stryker BiotechDose Finding Study of Bone Morphogenetic Protein 7 (BMP-7) in Subjects With Osteoarthritis (OA) of the Knee
NCT01133613phase1completed2010-05-012011-10-01Stryker BiotechDouble-Blind, Randomized, Single Dose Escalation Safety Study of Intraarticular Bone Morphogenic Protein (38A BMP-7) in Subjects With Osteoarthritis (OA) of the Knee

FDA applications (0)

No records yet.